When Amazon decided to jump into the prescription drug business, the narrative was predictable. Tech disruption. Lower prices. Convenience. A digital-first experience that would finally drag healthcare into the modern age. It sounded great. It still does—on paper.
But the reality is that the prescription drug business isn’t retail. It isn’t even close. And that’s why services like Amazon Pharmacy and the earlier acquisition of PillPack are running headfirst into the same quagmire that has frustrated every company that thinks medication fulfillment works like shipping books or electronics. Because prescriptions are not packages. They are regulated clinical decisions wrapped in layers of bureaucracy.
Healthcare Is Not E-Commerce
In Amazon’s world, the model is simple: customers order, warehouses fulfill, packages ship.
But prescriptions involve physicians, insurance formularies, prior authorizations, pharmacy benefit managers, state regulations, refill limits, and clinical checks that can halt the entire process. A prescription isn’t just an order—it’s a chain of approvals.
Even a perfectly designed digital system cannot eliminate friction, because much of it exists outside the pharmacy.
A doctor’s office may take two days to respond to a refill request. An insurer may reject a prescription because a cheaper drug must be tried first. A pharmacy benefit manager may require a prior authorization, forcing a patient into a paperwork loop.
Amazon can’t “Prime” its way around those obstacles.
The Insurance Maze Makes It Worse
What really traps mail-order pharmacy services is the insurance ecosystem.
Pharmacies operate within a system heavily controlled by pharmacy benefit managers such as CVS Caremark, Express Scripts, and Optum Rx. These companies decide which drugs are covered, what pharmacies are preferred, and what prices patients ultimately pay.
That means even if Amazon builds a seamless digital pharmacy, patients may still be pushed toward other mail-order services owned by PBMs. In other words, Amazon is trying to enter a market where the largest competitors also control the rules of the game.
That’s not disruption. That’s trench warfare.
Patients Don’t Always Want Mail Order
There’s another inconvenient reality: patients often want a pharmacy they can walk into.
They want a pharmacist to answer questions. They want medications immediately when a child is sick or when a doctor prescribes something after an appointment.
Waiting several days for delivery works for maintenance medications. It doesn’t work when a prescription is urgent or when something goes wrong.
That’s why the physical footprint of companies like CVS Health and Walgreens Boots Alliance still matters more than many tech executives expected.
Healthcare, it turns out, is stubbornly human.
The Hidden Operational Headaches
Then there are the operational challenges most outsiders underestimate.
Pharmacies handle rejected claims, dosage questions, prescriber clarifications, refill limits, controlled-substance regulations, and cold-chain shipping for specialty drugs. Every one of those issues can stop a shipment.
And when something goes wrong with a prescription, patients don’t want a chatbot.
They want a human being who understands both medicine and insurance.
Scaling that kind of support nationally is far harder than scaling a fulfillment center.
Amazon deserves credit for trying to modernize parts of the pharmacy industry. Digital refills, price transparency tools, and medication packaging innovations can all improve the patient experience.
But the bigger problem isn’t technology.
The problem is the U.S. drug distribution system itself.
Until the tangled relationships between insurers, PBMs, pharmacies, and providers change, even the most sophisticated tech company in the world will struggle to simplify prescription fulfillment.
That’s why Amazon’s mail-order pharmacy effort isn’t just facing growing pains.
It’s stuck in the same healthcare quagmire that has trapped everyone else.

You frame this very well. Amazon also suffers from “Not Invented Here Syndrome” which does not allow them to heed outside expertise.